(Q36920608)

17 August 2017

1 reference

title

Changing epidemiology of rare mould infections: implications for therapy (English)

1 reference

17 August 2017

1 reference

Anurag N Malani

1

1 reference

17 August 2017

Carol A Kauffman

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

67

1 reference

17 August 2017

issue

13

1 reference

17 August 2017

page(s)

1803-1812

1 reference

Aspergillus ustus infections among transplant recipients

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767130-00001

Taxonomy, biology, and clinical aspects of Fusarium species

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767130-00001

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

12 December 2020

Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections

1 reference

12 December 2020

Posaconazole as salvage therapy for zygomycosis

1 reference

12 December 2020

Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex

1 reference

12 December 2020

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature

1 reference

12 December 2020

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

1 reference

12 December 2020

Infections due to emerging and uncommon medically important fungal pathogens

1 reference

12 December 2020

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results

1 reference

12 December 2020

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

1 reference

12 December 2020

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

1 reference

12 December 2020

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

12 December 2020

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

1 reference

12 December 2020

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

1 reference

12 December 2020

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

1 reference

12 December 2020

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

1 reference

12 December 2020

Scedosporium/Pseudallescheria infections

1 reference

12 December 2020

Fusarium infections in critically ill patients

1 reference

12 December 2020

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

1 reference

12 December 2020

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

12 December 2020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

12 December 2020

Zygomycosis: the re-emerging fungal infection

1 reference

12 December 2020

Emerging fungal diseases

1 reference

12 December 2020

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

1 reference

12 December 2020

Efficacy of caspofungin against Aspergillus terreus

1 reference

12 December 2020

Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management

1 reference

12 December 2020

Zygomycosis: reemergence of an old pathogen

1 reference

12 December 2020

Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer

1 reference

12 December 2020

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers

1 reference

12 December 2020

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

12 December 2020

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

1 reference

12 December 2020

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

1 reference

12 December 2020

Role of granulocyte colony-stimulating factor in the treatment of mucormycosis

1 reference

12 December 2020

Antifungal susceptibilities of the species of the Pseudallescheria boydii complex

1 reference

12 December 2020

Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals

1 reference

12 December 2020

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.

1 reference

12 December 2020

In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates

1 reference

12 December 2020

Epidemiology of Aspergillus terreus at a university hospital

1 reference

12 December 2020

The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.

1 reference

12 December 2020

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

1 reference

12 December 2020

Zygomycosis in the 1990s in a tertiary-care cancer center

1 reference

12 December 2020

Deferiprone iron chelation as a novel therapy for experimental mucormycosis

1 reference

12 December 2020

Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion

1 reference

12 December 2020

Hematopoietic stem-cell transplantation

1 reference

12 December 2020

Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature

1 reference

12 December 2020

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

1 reference

12 December 2020

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

1 reference

12 December 2020

Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

1 reference

12 December 2020

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

1 reference

12 December 2020

Fusarium infection in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

Disseminated phaeohyphomycosis: review of an emerging mycosis

1 reference

12 December 2020

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

1 reference

12 December 2020

Itraconazole treatment of phaeohyphomycosis.

1 reference

12 December 2020

Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection

1 reference

12 December 2020

Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants

1 reference

12 December 2020

Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management

1 reference

12 December 2020

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

1 reference

12 December 2020

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

12 December 2020

Primary central nervous system phaeohyphomycosis: a review of 101 cases

1 reference

12 December 2020

Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus

1 reference

12 December 2020

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

1 reference

12 December 2020

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

1 reference

12 December 2020

Infections due to dematiaceous fungi in organ transplant recipients: case report and review

1 reference

12 December 2020

Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature

1 reference

12 December 2020

Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution

1 reference

12 December 2020

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

12 December 2020

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

12 December 2020

Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy

1 reference

12 December 2020

Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Posaconazole: a broad-spectrum triazole antifungal

1 reference

12 December 2020

Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia

1 reference

12 December 2020

Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review

1 reference

12 December 2020

In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications

1 reference

12 December 2020

Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis

1 reference

12 December 2020

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome

1 reference

12 December 2020

Mucormycosis: association with deferoxamine therapy

1 reference

12 December 2020

Voriconazole: a new triazole antifungal agent

1 reference

12 December 2020

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

12 December 2020

Pseudallescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses

1 reference

12 December 2020

Infections in solid-organ transplant recipients

1 reference

12 December 2020

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

1 reference

12 December 2020

10.2165/00003495-200767130-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1050414022

0 references

1 reference